National Research (NASDAQ:NRC) Stock Crosses Above Two Hundred Day Moving Average – What’s Next?

National Research Corporation (NASDAQ:NRC)’s stock price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $16.90 and traded as high as $19.22. National Research shares last traded at $18.67, with a volume of 78,454 shares trading hands.

Analysts Set New Price Targets

Separately, Weiss Ratings lowered shares of National Research from a “hold (c-)” rating to a “sell (d+)” rating in a report on Friday, March 6th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, National Research presently has an average rating of “Sell”.

National Research Trading Down 1.6%

The business’s 50-day moving average price is $17.28 and its 200 day moving average price is $16.96. The company has a debt-to-equity ratio of 5.48, a current ratio of 0.52 and a quick ratio of 0.52. The firm has a market capitalization of $423.61 million, a price-to-earnings ratio of 47.74 and a beta of 0.31.

National Research (NASDAQ:NRC) last announced its earnings results on Tuesday, April 28th. The company reported $0.21 earnings per share (EPS) for the quarter. National Research had a return on equity of 122.73% and a net margin of 6.52%.The company had revenue of $34.80 million for the quarter.

National Research Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 10th. Shareholders of record on Friday, June 26th will be paid a dividend of $0.16 per share. The ex-dividend date is Friday, June 26th. This represents a $0.64 annualized dividend and a yield of 3.4%. National Research’s dividend payout ratio is presently 164.10%.

Institutional Trading of National Research

Institutional investors and hedge funds have recently modified their holdings of the business. EverSource Wealth Advisors LLC raised its holdings in shares of National Research by 9,535.3% during the second quarter. EverSource Wealth Advisors LLC now owns 1,638 shares of the company’s stock worth $28,000 after purchasing an additional 1,621 shares during the period. Russell Investments Group Ltd. grew its position in shares of National Research by 85.6% during the 3rd quarter. Russell Investments Group Ltd. now owns 1,997 shares of the company’s stock valued at $26,000 after buying an additional 921 shares during the last quarter. Raymond James Financial Inc. bought a new stake in shares of National Research during the 2nd quarter valued at about $34,000. BNP Paribas Financial Markets grew its position in shares of National Research by 85.4% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,496 shares of the company’s stock valued at $32,000 after buying an additional 1,150 shares during the last quarter. Finally, Quadrant Capital Group LLC boosted its stake in National Research by 315.9% in the fourth quarter. Quadrant Capital Group LLC now owns 2,583 shares of the company’s stock valued at $48,000 after acquiring an additional 1,962 shares during the period. 47.26% of the stock is owned by institutional investors and hedge funds.

National Research Company Profile

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.